First database of combined clinical trials on brain disease made available to qualified researchers

A new database of more than 4,000 Alzheimer's disease patients who have participated in 11 industry-sponsored clinical trials was released today by the Coalition Against Major Diseases (http://c-path.org/CAMD.cfm).  This is the first database of combined clinical trials to be openly shared by pharmaceutical companies and made available to qualified researchers around the world. 

It is also the first effort of its kind to create a voluntary industry data standard that will help accelerate new treatment research on brain disease.  The data will enable researchers to more accurately predict the true course of Alzheimer's, Parkinson's, Huntington's, and other neuro-degenerative diseases, thereby enabling the design of more efficient clinical trials.